Detalhe da pesquisa
1.
Current approaches to management of high-risk multiple myeloma.
Am J Hematol
; 96(7): 854-871, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725367
2.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072687
3.
Functional, biochemical, molecular and clinical characterization of antithrombin c.1157T>C (p.Ile386Thr), a recurrent Polish variant with a founder effect.
Haematologica
; 108(10): 2803-2807, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021543
4.
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 24(3): e104-e111.e1, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135634
5.
Outcomes after biochemical or clinical progression in patients with multiple myeloma.
Blood Adv
; 7(6): 909-917, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413102
6.
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?
J Dermatolog Treat
; 33(5): 2674-2676, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32924664
7.
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
Blood Cancer J
; 12(12): 164, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473843
8.
Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study.
Antibiotics (Basel)
; 10(3)2021 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33805755
9.
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients.
Leuk Lymphoma
; 61(8): 1885-1893, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306794
10.
High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50â¯years using the standardized protocol for thrombophilia screening.
Thromb Res
; 176: 67-73, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30780006
11.
Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism.
Sci Rep
; 9(1): 72, 2019 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635605